Month: July 2020

  Every Second Matters for Mothers and BabiesTM—Uterine Balloon Tamponade (ESM-UBT) Every year, an estimated 130,000 women die from postpartum hemorrhage—uncontrolled blood loss from mothers during birth. This case study – the first in a series from the Launch and Scale Speedometer initiative – presents an overview of key elements that determined the pace of introduction and uptake of the ‘Every Second Matters for Mothers and BabiesTM-Uterine Balloon Tamponade’ to treat postpartum hemorrhage. This simple and inexpensive life-saving intervention, fashioned from a condom attached to a Foley catheter, was designed for use in low-resource settings. Read more about it here.

Join us on Wednesday, July 22, 8 am EDT, for The Future of Maternal, Newborn, and Child Health Innovation, co-hosted by Duke University and SL@B. Registration available HERE. Despite significant progress globally, persistent challenges in maternal, newborn, and child health continue to exist. Many solutions have emerged, ranging from evidence-based implementation programs to novel solutions that leapfrog conventional approaches. This forum brings together leaders from the public and private sectors, innovators, and researchers to present insights from the Saving Lives at Birth (SL@B) program, including findings from the recent program evaluation, and to discuss the path forward for MNCH innovation in the next decade. Topics include: What are the implications of the SL@B program evaluation? How can the MNCH funding and innovation community better respond to and address current challenges…

By Sowmya Rajan Creating a lasting impact that addresses complex global health challenges needs more than a game-changing innovation. Strong partnerships are needed at every stage of the innovation’s growth trajectory, from ideation, to implementation and scale. Some of these partnerships, established at the right time with the right stakeholders, can transform the innovation’s development and its pathway to scale. But what are the crucial partnerships that innovators need, and how can funders support innovators in establishing such partnerships? The Saving Lives at Birth (SL@B) program, a partnership of global health funders aimed at reducing maternal and infant mortality, provided funding to grantees and strategic connections. Through the Evaluation of SL@B (ESL@B) program, we examine how the program fostered partnerships and offered technical support to address innovators’ most critical needs…

Continuous innovation in the Maternal and Newborn Child Health sector plays a crucial role in reducing maternal and neonatal mortality. As new products and services continuously crop up in this space, human capital becomes key in implementing and scaling these innovations. However, setting up human capital structures is a challenge, especially in new organizations focused on the development of an innovation and perhaps only hiring for technical skills needed to develop the innovation. Human capital structures become increasingly critical as organizations attempt to hire and retain the right individuals, then motivate, reward, and compensate top talent. The Accelerating Saving Lives at Birth program recognized the important role that human capital plays in the launch and scale of innovations and developed a set of best practices outlined in the ‘team’ domain under the Framing…

By Andrea Taylor For social innovations, scaling is the key to impact. But how do these innovations scale, and how can funders, accelerators, and other partners accelerate that process? We took a close look at the experience of a sample of innovators funded by the Saving Lives at Birth program to answer this question. Their journeys provide insight into which factors are most helpful on the pathway to scale and how funders and other partners can support and speed up this process. Through semi-structured interviews with eleven innovator organizations, we learned that there are three key factors that accelerate the path to scaling: Preparation for scale at the early stages of innovation development. For some innovators, the funding application process served as a forcing mechanism to prompt early thinking about…

By Pratik Doshi, Research Assistant, Duke Global Health Innovation Center, MD Candidate at Duke University School of Medicine Joy Bhosai, Associate Director, Innovations in Healthcare and Duke Global Health Innovation Center Elina Urli Hodges, Assistant Director of Programs, Innovations in Healthcare and Duke Global Health Innovation Center Krishna Udayakumar, Executive Director, Innovations in HealthcareDirector, Duke Global Health Innovation Center Following a 2008 UN General Assembly call for human rights responsibilities from the pharmaceutical industry, low- and middle-income countries (LMICs) have benefited from an expansion of access to essential medicines. In 2015, the Sustainable Development Goals (SDGs) echoed this call in SDG Goal 3, which aims to ensure healthy lives and well-being for all people. While measurement and evaluation systems have accompanied many public-sector health programs, significant gaps remain in measuring the outcomes of private global…